ERBB2 and neoplasm: identified different tumor characteristics and different patients with different microenvironment subsets; moreover, their clustering data revealed that KIF5B, NOTCH2, NOTCH2NL and ERBB4 were highly expressed in primary carcinomas, whereas ERBB2, CDK12, and CLDN11 were highly expressed in metastatic carcinomas (13).